Literature DB >> 11887444

Predictors and prognostic value of oral hairy leukoplakia and oral candidiasis in South African HIV-infected patients.

M Badri1, G Maartens, R Wood.   

Abstract

BACKGROUND: Oral hairy leukoplakia and oral candidiasis diseases (OHL/OC) are common clinical manifestations of HIV/AIDS. Sparse literature exists from resource-limited countries on their incidence and impact on HIV-infected patients.
OBJECTIVE: To determine the predictors and prognosis of OHL/OC in HIV-infected patients.
METHODS: Patients were drawn from a cohort established in 1992 and prospectively followed until 1997 in the adult HIV clinics, University of Cape Town. Cox hazards regression models were fitted to determine the predictors of OHL/OC, and the association between OHL/OC and progression to AIDS and death.
RESULTS: 218 patients presenting with OHL/OC at their initial clinic visit were excluded. 205/772 patients developed OHL/OC (27.8 cases/100 years). White ethnicity (hazard ratio [HR] = 1.73, 95% CI 1.23-2.33), CD4+ count < 200 cells/(L (HR = 2.55, 95% CI 1.89-3.45), total lymphocyte count < 1250 cells/(L (HR = 1.72, 95% CI 1.28-2.31) and WHO stage 3 or 4 (HR = 2.61, 95% CI = 1.93-3.53) where variables predictive of increased hazard to developing OHL/OC. OHL/OC were independently associated with hazard of AIDS (HR = 3.65, 95% CI 1.89-6.69) and death (HR = 2.12, 95% CI 1.47-4.34).
CONCLUSIONS: The presence of OHL/OC in HIV-infected patients provides important prognostic information, and can be used as a cost-effective tool for screening patients in therapeutic interventions in resource-limited settings.

Entities:  

Mesh:

Year:  2001        PMID: 11887444

Source DB:  PubMed          Journal:  SADJ        ISSN: 1029-4864


  1 in total

1.  Predictors of mortality in patients initiating antiretroviral therapy in Durban, South Africa.

Authors:  Bisola O Ojikutu; Hui Zheng; Rochelle P Walensky; Zhigang Lu; Elena Losina; Janet Giddy; Kenneth A Freedberg
Journal:  S Afr Med J       Date:  2008-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.